(a) Changes in the scope of control of substances Chair: First, Commission will consider recommendations of WHO on 4 substances, namely: (a) Whether or not it wishes to include N-pyrrolidino protonitazene in Schedule I of the 1961 Convention as amended; (b) Whether or not it wishes to include N-pyrrolidino metonitazene in Schedule I of the …
Thailand
Committee of the Whole — Monday afternoon session
L.2. Promoting comprehensive, scientific evidence-based and multisectoral national systems of drug use prevention for children Chair: Welcome to the first CoW for the 68th CND session. This committee will have eight meetings, starting this afternoon through to Friday morning. We will suspend our work on Wednesday morning when voting in-person on agenda number 5. A …
Item 3. General Debate (Cont.)
Item 3. General Debate (Cont.) Iran. I wish to congratulate you for your election. I wish to thank the executive director for organizing this. The global issue of narcotic drugs is undergoing big issues. We are witnessing the emergence of NPS that have challenged monitoring and controlling systems. In order to have a more effective …
CND Reconvened 67th Session
Chair: Welcome back to the Reconvened 67th Session. We will continue the consideration on Item 4 on strategic management, budgetary and administrative questions. At our joint meeting with the CCPCJ yesterday, we considered under Agenda Item 4 the implementation of the consolidated for the biennium 2024-2025 for the UNODC. And the drugs proposed program plan …
CND Reconvened 67th Session – CND & CCPCJ joint meeting
MORNING SESSSION CCPCJ 1st VICE-Chair: Annotated Agenda. As you can see, it is proposed that the session today will address Item 4 on strategic management, budgetary, and administrative questions. As a joint meeting we are CND. Any outstanding elections for the FINGOV Bureau for 2024 will happen under that item as agreed upon by the …
CND Intersessional – Session 6 – Other Substantial Matters
2024 Thematic Discussions on the Implementation of All International Drug Policy Commitments, Following-up to the 2019 Ministerial Declaration Other Substantial Matters proposed by Member States • Challenges to the identification of new illicit drugs: Discussion on strategies and approaches by laboratories to enhance the capacity of forensic personnel and harnessing technology to improve identification methods …